Ideas
Gold and silver face uncertainty-driven volatility.
Precious metals saw a sharp drop and a volatile rebound, with volatility staying concentrated in metals. Gold and, to a lesser extent, silver are supported by extreme uncertainty across markets as investors seek somewhere to put money; investors are still repricing after a huge run-up, suggesting more volatility.
Palantir beat and upselling supports growth.
Palantir delivered a comfortable earnings beat, with revenue growth around 70% and a full-year revenue forecast above $7 billion, well ahead of expectations. Analysts see excellent results, strong upselling with government clients such as the Defense Department and ICE, and a push into the enterprise/private sector in 2026; that could help address valuation concerns after the stock's huge run.
AMD earnings test AI share gains.
AMD reports after the close, with the stock up 100% year-to-date. The key question is whether AMD is taking AI accelerator market share from NVIDIA; memory/HBM shortages and rising prices from Samsung could be a headwind. This is an event-driven setup to watch.
AI chip complexity boosts Teradyne testing demand.
Teradyne shares surged after the company provided a revenue forecast ahead of analyst expectations. Analysts say Teradyne should benefit greatly from AI chips becoming more complex because that will increase demand for its testing services.
AI legal tool threatens professional publishers.
Professional publishers, including RELX, sold off after Anthropic revealed a tool that could be used by legal teams. The concern is that AI legal tools could disrupt the legal-information and publishing business, pressuring the sector.
Resilient US economy supports global equities.
The U.S. economy remains resilient, supported by sizable tax rebates, upper-income consumer spending and ongoing AI capex that has added materially to growth. She sees the economy in a sweet spot that can support risk sentiment and prop up global equities, with tech earnings leadership persisting but narrowing as the bull market broadens out.
EM debt attractive on carry and inflows.
Emerging market debt looks attractive after three consecutive years of sizable outflows; sentiment is improving with more than $6 billion of inflows year-to-date, supported by attractive carry and a constructive global backdrop. This is where she sees investors looking for opportunities.
Fed ambiguity favors Treasury curve steepener.
With a Warsh-led Fed, there is ambiguity between his hawkish history and recent dovish alignment with the administration. She is leaning into curve steepening: balance-sheet restraint tends to lift long-end yields relative to front-end yields, and U.S. fiscal dynamics add to the case for a steeper curve.
Pfizer faces bumpy 2026 patent cliff.
Pfizer faces a challenging 2026 with little or no sales growth as blockbuster patents expire and related revenues become less meaningful. New lung-cancer and obesity drug readouts and more aggressive cost cuts could improve the story, but otherwise it looks like a bumpy year.
Merck patent cliff needs catalysts.
Merck's key issue is handling the patent cliff, especially for its HPV vaccine, and investors will focus on long-term strategy rather than near-term earnings. New drugs may fill the gap but face regulatory hurdles, so positive catalysts or more M&A are needed; details on the Trump most-favored-nation deal are also a watch item.
This Bloomberg Markets video, published February 03, 2026,
features Sam, Tom Mackenzie, Chloe, Laura Cooper, Sonja Wint
discussing GLD, SILVER, PLTR, AMD, TER, RELX, Professional publishers, VT, EMB, US Treasury Curve Steepener, PFE, MRK.
10 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Sam,
Tom Mackenzie,
Chloe,
Laura Cooper,
Sonja Wint
· Tickers:
GLD,
SILVER,
PLTR,
AMD,
TER,
RELX,
Professional publishers,
VT,
EMB,
US Treasury Curve Steepener,
PFE,
MRK
